Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Anxiety Is an Independent Risk Factor for Bone Fractures

Mary Beth Nierengarten  |  Issue: November 2018  |  November 18, 2018

MikeDotta / shutterstock.com

MikeDotta / shutterstock.com

Higher anxiety levels in postmenopausal women may put them at increased risk of fracture and should be considered when assessing a woman’s risk of osteoporosis as well. This is the conclusion of a study recently published in the journal Menopause that looked at the role of anxiety in bone health.1 Specifically, the study examined the link between anxiety levels and bone mineral density (BMD) and fracture risk among postmenopausal women.

Previous research has focused mainly on the psychological effects of osteoporosis and fracture on quality of life and anxiety levels, according to lead author of the study, Antonino Catalano, MD, PhD, Department of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy. Dr. Catalano notes data from this research suggest that “in comparison with healthy women, osteoporotic women show a weakened quality of life and increased anxiety levels.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What has not been looked at and what is new in this study is how anxiety levels may influence fracture risk. “We looked in the direction from anxiety levels to bone health [in postmenopausal women],” says Dr. Catalano.

The study found higher anxiety levels in postmenopausal women were linked to low bone mineral density and higher fracture risk, independent of other classical risk factors for osteoporosis, such as age, menopausal age, years since menopause and body mass index.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Our findings suggest a possible new clinical risk factor for osteoporosis that could be measured to improve our ability to identify women at risk for fractures,” says Dr. Catalano.

The Study

The cross-sectional study included 192 white women recruited from a single institution in Messina, Italy. All women underwent evaluation to assess their anxiety level by completing 14 symptom-defining elements of anxiety included in the Hamilton Anxiety Rating Scale (HAMA). These elements include psychological symptoms of anxiety (e.g., tension, fear, sleep and memory issues, and depression), somatic symptoms of anxiety (e.g., aches and pains, ear or eye problems, chest tightness, gastrointestinal symptoms), as well as observed behaviors (e.g., fidgety or restlessness). Based on the results, women were grouped by level from mild (HAMA-1; n=87) to moderate (HAMA-2; n=48) to severe anxiety (HAMA-3; n=57).

All women also underwent evaluation to assess bone mineral density using standard imaging, as well as fracture risk using a computer-based algorithm (i.e., the Fracture Risk Assessment Tool) that calculates the 10-year probability of a major fracture.

The study found the women with the lowest levels of anxiety (HAMA-1) had a significantly lower 10-year probability of a major fracture compared with women who had the highest levels of anxiety (HAMA-3) (20.44% vs. 24.94%, respectively; P=0.03). Women with moderate levels of anxiety (HAMA-2) also had a significantly lower probability of fracture risk than the women with the highest anxiety levels (17.91% vs. 24.94%, respectively; P=0.002).

Women with the highest levels of anxiety also had significantly lower BMD than women with the lowest levels of anxiety. When looking at bone density of the lumbar spine and femoral neck, women with the highest anxiety levels had significantly lower T-score values than women at the lowest levels of anxiety (see Table 1).

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Osteoporosis

Related Articles

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    New Treatments Needed to Prevent Fractures in Osteoporosis

    June 1, 2014

    Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences